Literature DB >> 34175748

Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.

Darae Ko1, Sarah R Preis2, Andrew D Johnson3, Ramachandran S Vasan4, Emelia J Benjamin4, Naomi M Hamburg5, Gary F Mitchell6.   

Abstract

INTRODUCTION: Association between arterial vascular dysfunction and risk of venous thromboembolism (VTE) is uncertain. We determined the associations between comprehensive measures of arterial vascular function and risk of incident VTE in a community-based cohort study with robust longitudinal follow-up.
MATERIALS AND METHODS: In the Framingham Heart Study Original, Offspring, Third Generation, and Omni cohorts, we measured carotid-femoral pulse wave velocity and central pulse pressure (n = 8261, age 51.5 ± 15.5 years, 54% women), flow-mediated dilation and hyperemic velocity (n = 6540, age 47.9 ± 14.1 years, 54% women), and peripheral arterial tonometry ratio (n = 4998, age 54.3 ± 16.0 years, 52% women). Deep venous thrombosis and pulmonary embolism were diagnosed with imaging studies and adjudicated by three Framingham Heart Study physicians. RESULTS AND
CONCLUSIONS: The rate of incident VTE was 1.6-2.1 per 1000 person-years during mean follow-up of 8.5-11.2 years. In age- and sex-adjusted Cox proportional hazards regression models, carotid-femoral pulse wave velocity was associated with increased risk of VTE (HR 1.32, 95% CI 1.05-1.66, p = 0.02), however the association was no longer statistically significant after multivariable adjustment (HR 1.24, 95% CI 0.96-1.61, p = 0.10). None of the other vascular variables were associated with the risk of VTE in any of the models. In our comprehensive examination of arterial vascular function and risk of VTE, we did not observe any association between select arterial function measures and risk of VTE after multivariable adjustment.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Endothelial function; Venous thromboembolism

Mesh:

Year:  2021        PMID: 34175748      PMCID: PMC8297907          DOI: 10.1016/j.thromres.2021.06.012

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   10.407


  26 in total

Review 1.  Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature.

Authors:  Francesco Dentali; Vera Gessi; Rossella Marcucci; Monica Gianni; Anna Maria Grandi; Massimo Franchini
Journal:  Semin Thromb Hemost       Date:  2017-03-27       Impact factor: 4.180

2.  Assessment of arterial stiffness in patients with venous thromboembolism: Separate or continuous circuits?

Authors:  Ahmet Çağrı Aykan; Engin Hatem; Ezgi Kalaycıoğlu; Tayyar Gökdeniz; Can Yucel Karabay
Journal:  Phlebology       Date:  2016-05-27       Impact factor: 1.740

3.  Relation of brachial and digital measures of vascular function in the community: the Framingham heart study.

Authors:  Naomi M Hamburg; Joseph Palmisano; Martin G Larson; Lisa M Sullivan; Birgitta T Lehman; Ramachandran S Vasan; Daniel Levy; Gary F Mitchell; Joseph A Vita; Emelia J Benjamin
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

Review 4.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

5.  Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.

Authors:  Bakhtawar K Mahmoodi; Mary Cushman; Inger Anne Næss; Matthew A Allison; Willem J Bos; Sigrid K Brækkan; Suzanne C Cannegieter; Ron T Gansevoort; Philimon N Gona; Jens Hammerstrøm; John-Bjarne Hansen; Susan Heckbert; Anders G Holst; Susan G Lakoski; Pamela L Lutsey; JoAnn E Manson; Lisa W Martin; Kunihiro Matsushita; Karina Meijer; Kim Overvad; Eva Prescott; Marja Puurunen; Jacques E Rossouw; Yingying Sang; Marianne T Severinsen; Jur Ten Berg; Aaron R Folsom; Neil A Zakai
Journal:  Circulation       Date:  2016-11-09       Impact factor: 29.690

6.  Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study.

Authors:  Gary F Mitchell; Helen Parise; Joseph A Vita; Martin G Larson; Elaine Warner; John F Keaney; Michelle J Keyes; Daniel Levy; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Hypertension       Date:  2004-07-12       Impact factor: 10.190

7.  Epidemiology of venous thromboembolism in the Framingham Heart Study.

Authors:  Marja K Puurunen; Philimon N Gona; Martin G Larson; Joanne M Murabito; Jared W Magnani; Christopher J O'Donnell
Journal:  Thromb Res       Date:  2016-06-29       Impact factor: 3.944

8.  A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

Authors:  Robert J Glynn; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Paul M Ridker
Journal:  N Engl J Med       Date:  2009-03-29       Impact factor: 91.245

9.  Endothelial dysfunction in patients with spontaneous venous thromboembolism.

Authors:  Rino Migliacci; Cecilia Becattini; Raffaele Pesavento; Giovanni Davi; Maria Cristina Vedovati; Giuseppe Guglielmini; Emanuela Falcinelli; Giovanni Ciabattoni; Fabio Dalla Valle; Paolo Prandoni; Giancarlo Agnelli; Paolo Gresele
Journal:  Haematologica       Date:  2007-06       Impact factor: 9.941

10.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.